1. Home
  2. PBYI vs GWRS Comparison

PBYI vs GWRS Comparison

Compare PBYI & GWRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • GWRS
  • Stock Information
  • Founded
  • PBYI 2010
  • GWRS 2003
  • Country
  • PBYI United States
  • GWRS United States
  • Employees
  • PBYI N/A
  • GWRS N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • GWRS Water Supply
  • Sector
  • PBYI Health Care
  • GWRS Utilities
  • Exchange
  • PBYI Nasdaq
  • GWRS Nasdaq
  • Market Cap
  • PBYI 263.4M
  • GWRS 276.4M
  • IPO Year
  • PBYI N/A
  • GWRS 2010
  • Fundamental
  • Price
  • PBYI $4.91
  • GWRS $8.97
  • Analyst Decision
  • PBYI Strong Buy
  • GWRS
  • Analyst Count
  • PBYI 1
  • GWRS 0
  • Target Price
  • PBYI $7.00
  • GWRS N/A
  • AVG Volume (30 Days)
  • PBYI 635.5K
  • GWRS 65.8K
  • Earning Date
  • PBYI 11-06-2025
  • GWRS 11-12-2025
  • Dividend Yield
  • PBYI N/A
  • GWRS 3.41%
  • EPS Growth
  • PBYI 59.87
  • GWRS N/A
  • EPS
  • PBYI 0.74
  • GWRS 0.17
  • Revenue
  • PBYI $211,995,000.00
  • GWRS $55,468,000.00
  • Revenue This Year
  • PBYI N/A
  • GWRS $8.40
  • Revenue Next Year
  • PBYI N/A
  • GWRS $8.39
  • P/E Ratio
  • PBYI $6.61
  • GWRS $52.85
  • Revenue Growth
  • PBYI N/A
  • GWRS 7.06
  • 52 Week Low
  • PBYI $2.32
  • GWRS $8.90
  • 52 Week High
  • PBYI $6.12
  • GWRS $13.68
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 46.97
  • GWRS 26.91
  • Support Level
  • PBYI $4.58
  • GWRS $9.98
  • Resistance Level
  • PBYI $6.12
  • GWRS $10.16
  • Average True Range (ATR)
  • PBYI 0.40
  • GWRS 0.31
  • MACD
  • PBYI -0.05
  • GWRS -0.13
  • Stochastic Oscillator
  • PBYI 20.06
  • GWRS 1.65

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About GWRS Global Water Resources Inc.

Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix, Arizona. It operates within the State of Arizona.

Share on Social Networks: